Desmopressin (DDAVP) in the Treatment of Bleeding Disorders: The First 20 Years
Open Access
- 1 October 1997
- journal article
- Published by American Society of Hematology in Blood
- Vol. 90 (7), 2515-2521
- https://doi.org/10.1182/blood.v90.7.2515
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: A multicenter, double-blind studyHepatology, 1993
- A Trial of Desmopressin to Reduce Blood Loss in Patients Undergoing Spinal Fusion for Idiopathic ScoliosisAnesthesia & Analgesia, 1992
- DDAVP—The Multipotent Drug in Patients With CoagulopathiesTransfusion Medicine Reviews, 1991
- DDAVP-induced release of Von Willebrand factor from endothelial cells in vitro: The effect of plasma and blood cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
- A Trial of Desmopressin (1-Desamino-8-D-Arginine Vasopressin) to Reduce Blood Loss in Uncomplicated Cardiac SurgeryNew England Journal of Medicine, 1989
- Conjugated Estrogens for the Management of Bleeding Associated with Renal FailureNew England Journal of Medicine, 1986
- Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac SurgeryNew England Journal of Medicine, 1986
- Platelet Aggregation Induced by I-Desamino-8-D-Arginine Vasopressin (dDAVP) in Type IIb von Willebrand's DiseaseNew England Journal of Medicine, 1983
- DDAVP: A useful alternative to blood components in moderate hemophilia A and von Willebrand diseaseThe Journal of Pediatrics, 1983
- Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in UremiaNew England Journal of Medicine, 1983